Eight medical device companies with operations in the Bay State made Forbes magazine’s “Global 2000” list.
The annual list ranks the world’s largest companies using a series of metrics including sales, profits, assets and market value.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Eight medical device companies with operations in the Bay State made Forbes magazine’s “Global 2000” list.
The annual list ranks the world’s largest companies using a series of metrics including sales, profits, assets and market value.
Hurting hospital patients
Injuries from falls, bedsores and burns all sound like reasons to go to the hospital. But according to a new state Department of Public Health report, those are among the injuries about 300 people suffered in Massachusetts hospitals last year.
Aspect Medical Systems Inc. cut a deal with a New York investment fund rather than face a protracted and messy board fight.
The Norwood-based brain-monitoring equipment maker said it will support the nomination of Jon Biro and Melvin Keating, both of First Biomed LLC, to its board of directors for three-year terms starting in June. Keating will also be given a seat on the compensation committee and Biro will be appointed to the auditing committee.
Johns Hopkins University is jumping on the gifts ban bandwagon, following Massachusetts in outright forbidding its doctors from receiving most gifts from medical device and pharmaceutical manufacturers, the Wall Street Journal reported.
The school’s ban (PDF) bars doctors from receiving gifts, entertainment or food from medical device and drug companies..
Brad Perriello
You’d think after about 20 years, questions about the efficacy of stents would be settled. You’d be wrong.
Even as players large and small scramble to get the first bioabsorbable product to market, there are conflicting reports about the best way to treat heart disease — devices or drugs?
Vital signs are improving at the Massachusetts Institute of Technology — at least, techniques to measure them are, according to MIT Tech Talk.
Engineers at the school, led by mechanical engineering professor Harry Asada, built a wearable blood pressure cuff that provides 24-hour monitoring.
The idea is to allow physicians to track vital signs on a continuous basis, to improve treatment of such conditions as sleep apnea, hypertension and heart disease.
And, given the accumulation of enought data, the device might eventually allow doctors to predict when heart attacks are due, Asada told the newspaper.
Covidien head honcho Richard Meelia is leaving his post on the board of Haemonetics Corp. so that he can spend more time with his company.
The Braintree-based blood management company said Meelia is leaving the board “in order to spend more professional time on Covidien’s operations.”
Meelia is leaving two years before his term was set to end in 2011. He joined the board in 2005 and was re-elected in July 2008.
NMT Medical Inc. said it will release data from the clinical trial of its StarFlex implant.
Analysis of data from the study, which aims to determine whether the device can help prevent stroke or ischemia from patent formane ovale, is due to be released during the fourth quarter of 2010. PFO is a defect in the septum separating the heart’s atrial chambers.
The StarFlex implant closes the defect, preventing venous blood from returning to the body without being oxygenated by the lungs.
You are receiving this newsletter because you were part of a group selected to preview www.massdevice.com. The unsubscribe link in our “welcome” newsletter was broken. Please use the following link to unsubscribe if you do not want to receive our newsletters:
We apologize for any inconvenience and thank you for your help and support while we iron out a few last wrinkles before our public launch. Brian Johnson – Publisher, co-founder & Brad Perriello – Executive editor, co-founder
The federal Food & Drug Administration is gearing up to review 25 types of medical devices made before 1976, the year the watchdog agency got its brief to review new medical technologies.
Makers of the devices will have to submit safety and effectiveness data to the FDA within 120 days, which it will use to evaluate the risk level for each device type.
If found to be “of high risk to consumers,” the devices will have to undergo “the agency’s most stringent premarket review process,” according to a press release.
A Missouri-based subsidiary of Mansfield’s Covidien, Mallinckrodt Inc., accused a pair of Italian life science firm Bracco SpA‘s American divisions of patent infringement, The Boston Globe reported.
Hazelwood, Mo.-based Mallinckrodt sued Bracco’s Lake Success, N.Y.-based E-Z-EM Inc. and Acist Medical Systems Inc. of Eden Prairie, Minn., in Delaware federal court for allegedly infringing its patent for a device used to inject chemicals into MRI patients.